| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4024405 | Journal Français d'Ophtalmologie | 2006 | 9 Pages |
Abstract
On the basis of this first nationwide study, it can be estimated that the prevalence of subjects treated with IOP-lowering topical medications is about 1.2 million in France. The number of daily doses appears to influence compliance.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
C. Delcourt, A. Bron, C. Baudouin, P. Denis, J.-P. Nordmann, J.-P. Renard, J.-F. Rouland, E. Sellem, M. Stephan, F. Levrat, A. Solesse,